Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: A North Central Cancer Treatment Group Study

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 135-141

  Rowland Jr , K M ^a   Loprinzi, C L ^a   Shaw, E G ^a   Maksymiuk, A W ^a   Kuross, S A ^a   Jung, S H ^a   Kugler, J W ^a   Tschetter, L K ^a   Ghosh, C ^a   Schaefer, P L ^a   Owen, D ^a   Washburn Jr , J H ^a   Webb, T A ^a   Mailliard, J A ^a   Jett, J R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MEGESTROL ACETATE; ONDANSETRON; PLACEBO; VINCRISTINE;

ADVANCED CANCER; ANOREXIA; ARTICLE; BLOOD TOXICITY; CACHEXIA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; EDEMA; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PHLEBITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; VOMITING; WEIGHT REDUCTION;

EID: 9044244145     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.135     Document Type: Article

References (25)

1. Morstyn G, Ihde DC, Lichter AS, et al: Small cell lung cancer 1973-1983: Early progress and recent obstacles. Int J Radiat Oncol Biol Phys 10:515-539, 1984
2. Feld R, Evans WK, DeBoer G, et al: Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol 2:294-304, 1984
3. Evans WK, Shepherd FA, Feld R, et al: VP-16 and cisplatin as first line therapy for small cell lung cancer. J Clin Oncol 3:1471-1477, 1985
4. Roth BJ, Johnson DH, Einhorn LH, et al: Randomized study of cyclophosphamide, doxorubicin and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small cell lung cancer: A phase III trial of the Southeastern Cancer Study Group. J Clin Oncol 10:282-291, 1992
5. Wiesenfeld M, Jett JR, Su JQ, et al: Phase II trial of edatrexate in small cell lung cancer. Cancer 73:1189-1193, 1994
6. Maksymiuk AW, Jett JR, Earle JD, et al: Sequencing and schedule effects of cisplatin plus etoposide in small cell lung cancer: Results of a North Central Cancer Treatment Group randomized clinical trial. J Clin Oncol 12:70-76, 1994
7. Tchekmedyian NS, Tait N, Moody M, et al: High-dose megestrol acetate: A possible treatment for cachexia. JAMA 257:1195-1198, 1987
8. Schacter L, Rozenweig M, Canetta R, et al: Megestrol acetate: Clinical experience. Cancer Treat Rev 16:49-63, 1989
9. Kornblith AB, Hollis DR, Zucherman E, et al: Effect of megestrol acetate on quality of life in a dose-response trial in women with advanced breast cancer. J Clin Oncol 11:2081-2089, 1993
10. Heckmayr M, Gatzemeier U: Megestrol acetate in cachectic patients with advanced bronchogenic cancer. Oncology 13:285-287, 1990
11. Loprinzi CL, Ellison NM, Schaid DJ, et al: A controlled trial of megestrol acetate in patients with cancer anorexia and/or cachexia. J Natl Cancer Inst 82:1127-1132, 1990
12. Feliu J, Gonzalez-Baron M, Berrocal A, et al: Usefulness of megestrol acetate in cancer cachexia and anorexia. Am J Clin Oncol 15:436-440, 1992
13. Heckmayr M, Gatzemeier U: Treatment of cancer weight loss in patients with advanced lung cancer. Oncology 49:332-334, 1992
14. Tchekmedyian NS, Hickman M, Siau J, et al: Megestrol acetate in cancer anorexia and weight loss. Cancer 69:1268-1274, 1992
15. Loprinzi CL, Schaid DJ, Dose AM, et al: Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol 11:152-154, 1993
16. Tattersall MHN, Simes RJ, Lumbley T, et al: Improved quality of life (QoL) with megestrol acetate for patients with advanced non-endocrine sensitive cancer: A placebo controlled randomized trial. Proc Am Soc Clin Oncol 13:435, 1994 (abstr 1497)
17. Loprinzi CL, Laune JA, Wieand HS, et al: Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 12:601-607, 1994
18. Spitzer WO, Dobson AJ, Hall J, et al: Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chronic Dis 34:585-597, 1981
19. Liang KY, Zeger SL: Longitudinal data analysis using generalized linear models. Biometrika 73:13-22, 1986
20. Loprinzi CL, Michalak, JC, Schaid DJ, et al: Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 11:762-767, 1993
21. Fleishman SB, Kosty M, Herndon J, et al: Quality of life (QoL) predicts survival in advanced non-small cell lung cancer. Proc Am Soc Clin Oncol 13:431, 1994 (abstr 1479)
22. Fisher B, Redmond C, Widkerhan DL, et al: Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J CHn Oncol 7:572-582, 1989
23. von Roenn J: Megestrol acetate in patients with AIDS related cachexia. Ann Intern Med 121:393-399, 1994
24. Loprinzi CL, Jensen MD, Jian S, et al: Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc 67:1160-1162, 1992
25. Leinung MC, Liporace R, Miller CH: Induction of adrenal suppression by megestrol acetate in patients with AIDS. Ann Intern Med 122:843-845, 1995